메뉴 건너뛰기




Volumn 157, Issue 2, 2014, Pages 147-155

Supplementary chromium(III) propionate complex does not protect against insulin resistance in high-fat-fed rats

Author keywords

Chromium(III) propionate complex; High fat diet; Insulin resistance; Rats

Indexed keywords

ANIMAL FEED; ANIMALS; BLOOD GLUCOSE; CHROMIUM; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; INSULIN; INSULIN RESISTANCE; KIDNEY; LIPIDS; LIVER; MALE; PROPIONATES; RATS; RATS, WISTAR; TRACE ELEMENTS;

EID: 84895083581     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-013-9877-3     Document Type: Article
Times cited : (17)

References (51)
  • 1
    • 82955247909 scopus 로고    scopus 로고
    • IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
    • 22079683 10.1016/j.diabres.2011.10.029
    • Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94(3):311-321
    • (2011) Diabetes Res Clin Pract , vol.94 , Issue.3 , pp. 311-321
    • Whiting, D.R.1    Guariguata, L.2    Weil, C.3    Shaw, J.4
  • 2
    • 39749147110 scopus 로고    scopus 로고
    • Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes
    • 1:CAS:528:DC%2BD1cXitlGnurg%3D 18200017 10.1038/nrm2327
    • Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9:193-205
    • (2008) Nat Rev Mol Cell Biol , vol.9 , pp. 193-205
    • Muoio, D.M.1    Newgard, C.B.2
  • 3
    • 33847119543 scopus 로고    scopus 로고
    • Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: Systematic review and meta-analysis
    • 17237299 10.1136/bmj.39063.689375.55
    • Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334:299
    • (2007) BMJ , vol.334 , pp. 299
    • Gillies, C.L.1    Abrams, K.R.2    Lambert, P.C.3    Cooper, N.J.4    Sutton, A.J.5    Hsu, R.T.6    Khunti, K.7
  • 4
    • 33749071019 scopus 로고    scopus 로고
    • Chromium. A case study in how not to perform nutritional research
    • 1:CAS:528:DC%2BD28XhtVGisrvJ
    • Stallings D, Vincent JB (2006) Chromium. A case study in how not to perform nutritional research. Curr Topics Nutraceut Res 4:89-112
    • (2006) Curr Topics Nutraceut Res , vol.4 , pp. 89-112
    • Stallings, D.1    Vincent, J.B.2
  • 6
    • 77950477637 scopus 로고    scopus 로고
    • Chromium: Celebrating 50 years as an essential element?
    • 1:CAS:528:DC%2BC3cXkt1yhs7g%3D 20372701 10.1039/b920480f
    • Vincent JB (2010) Chromium: celebrating 50 years as an essential element? Dalton Trans 39:3787-3794
    • (2010) Dalton Trans , vol.39 , pp. 3787-3794
    • Vincent, J.B.1
  • 7
    • 84866353145 scopus 로고    scopus 로고
    • The need for combined inorganic, biochemical, and nutritional studies of chromium(III)
    • 1:CAS:528:DC%2BC38XhtlGht7%2FN 22976981 10.1002/cbdv.201100440
    • Vincent JB, Love ST (2012) The need for combined inorganic, biochemical, and nutritional studies of chromium(III). Chem Biodivers 9:1923-1940
    • (2012) Chem Biodivers , vol.9 , pp. 1923-1940
    • Vincent, J.B.1    Love, S.T.2
  • 8
    • 2342591295 scopus 로고    scopus 로고
    • Absorption of the biomimetic chromium cation triaqua-l-oxo- hexapropionatotrichromium(III) in rats
    • 1:CAS:528:DC%2BD2cXjsVyrur4%3D 15073413 10.1385/BTER:98:2:159
    • Clodfelder BJ, Chang C, Vincent JB (2004) Absorption of the biomimetic chromium cation triaqua-l-oxo-hexapropionatotrichromium(III) in rats. Biol Trace Elem Res 98:159-169
    • (2004) Biol Trace Elem Res , vol.98 , pp. 159-169
    • Clodfelder, B.J.1    Chang, C.2    Vincent, J.B.3
  • 9
    • 17644365750 scopus 로고    scopus 로고
    • + increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats
    • 1:CAS:528:DC%2BD2MXjtVWmt7o%3D 15625608 10.1007/s00775-004-0618-0
    • + increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats. J Biol Inorg Chem 10:119-130
    • (2005) J Biol Inorg Chem , vol.10 , pp. 119-130
    • Clodfelder, B.J.1    Gullick, B.M.2    Lukaski, H.C.3    Neggers, Y.4    Vincent, J.B.5
  • 10
    • 0036937242 scopus 로고    scopus 로고
    • + decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type i diabetic rats
    • 1:CAS:528:DC%2BD38Xotlajtrw%3D 12203022 10.1007/s00775-002-0366-y
    • + decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats. J Biol Inorg Chem 7:852-862
    • (2002) J Biol Inorg Chem , vol.7 , pp. 852-862
    • Sun, Y.1    Clodfelder, B.J.2    Shute, A.A.3    Irvin, T.4    Vincent, J.B.5
  • 11
    • 77956339657 scopus 로고    scopus 로고
    • Chromium(III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model
    • 20633590 10.1016/j.fct.2010.07.008
    • Król E, Krejpcio Z (2010) Chromium(III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model. Food Chem Toxicol 48:2791-2796
    • (2010) Food Chem Toxicol , vol.48 , pp. 2791-2796
    • Król, E.1    Krejpcio, Z.2
  • 12
    • 80054857846 scopus 로고    scopus 로고
    • Evaluation of anti-diabetic potential of chromium(III) propionate complex in high-fat diet fed and STZ injected rats
    • 21939728 10.1016/j.fct.2011.09.006
    • Król E, Krejpcio Z (2011) Evaluation of anti-diabetic potential of chromium(III) propionate complex in high-fat diet fed and STZ injected rats. Food Chem Toxicol 49(12):3217-3223
    • (2011) Food Chem Toxicol , vol.49 , Issue.12 , pp. 3217-3223
    • Król, E.1    Krejpcio, Z.2
  • 13
    • 84870711817 scopus 로고    scopus 로고
    • Effects of combined dietary chromium(III) propionate complex and thiamine supplementation on insulin sensitivity, blood biochemical indices, and mineral levels in high-fructose-fed rats
    • 3510416 23065486 10.1007/s12011-012-9515-5
    • Król E, Krejpcio Z, Michalak S, Wójciak RW, Bogdański P (2012) Effects of combined dietary chromium(III) propionate complex and thiamine supplementation on insulin sensitivity, blood biochemical indices, and mineral levels in high-fructose-fed rats. Biol Trace Elem Res 150(1-3):350-359
    • (2012) Biol Trace Elem Res , vol.150 , Issue.1-3 , pp. 350-359
    • Król, E.1    Krejpcio, Z.2    Michalak, S.3    Wójciak, R.W.4    Bogdański, P.5
  • 14
    • 0027487229 scopus 로고
    • AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet
    • 1:CAS:528:DyaK2cXltlegsw%3D%3D 8229312
    • Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951
    • (1993) J Nutr , vol.123 , pp. 1939-1951
    • Reeves, P.G.1    Nielsen, F.H.2    Fahey Jr., G.C.3
  • 15
    • 37049121889 scopus 로고
    • Chemistry of polynuclear compounds. Part VI. Magnetic properties of trimeric chromium and iron carboxylates
    • Earnshaw A, Figgis BN, Lewis J (1966) Chemistry of polynuclear compounds. Part VI. Magnetic properties of trimeric chromium and iron carboxylates. J Chem Soc A 1656-1663
    • (1966) J Chem Soc A , pp. 1656-1663
    • Earnshaw, A.1    Figgis, B.N.2    Lewis, J.3
  • 17
    • 0036177713 scopus 로고    scopus 로고
    • Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus
    • 1:CAS:528:DC%2BD38XitVersr4%3D 11861436
    • Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M (2002) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48:436-472
    • (2002) Clin Chem , vol.48 , pp. 436-472
    • Sacks, D.B.1    Bruns, D.E.2    Goldstein, D.E.3    Maclaren, N.K.4    McDonald, J.M.5    Parrott, M.6
  • 18
    • 0032768274 scopus 로고    scopus 로고
    • A homogenous assay for the selective measurement of LDL-cholesterol in serum. Enzymatic selective protection method
    • Miki Y (1999) A homogenous assay for the selective measurement of LDL-cholesterol in serum. Enzymatic selective protection method. Clin Lab 45:398-401
    • (1999) Clin Lab , vol.45 , pp. 398-401
    • Miki, Y.1
  • 20
    • 0025177136 scopus 로고
    • Falsely low estimation of triglycerides in lipemic plasma by the enzymatic triglyceride method with modified Trinder's chromogen
    • 1:STN:280:DyaK3c7ltVGhtA%3D%3D 2406041
    • Shephard MD, Whiting MJ (1990) Falsely low estimation of triglycerides in lipemic plasma by the enzymatic triglyceride method with modified Trinder's chromogen. Clin Chem 36:325-329
    • (1990) Clin Chem , vol.36 , pp. 325-329
    • Shephard, M.D.1    Whiting, M.J.2
  • 21
    • 0037212005 scopus 로고    scopus 로고
    • New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: Preliminary upper reference limits obtained in hospitalized subjects
    • 1:CAS:528:DC%2BD38XptlWmsr0%3D 12482620 10.1016/S0009-8981(02)00341-8
    • Schumann G, Klauke R (2003) New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin Chim Acta 327:69-79
    • (2003) Clin Chim Acta , vol.327 , pp. 69-79
    • Schumann, G.1    Klauke, R.2
  • 22
    • 0002272382 scopus 로고    scopus 로고
    • Renal function and nitrogen metabolites
    • C.A. Burtis E.R. Ashwood (eds) Saunders Philadelphia
    • Newmann DJ, Price CP (1999) Renal function and nitrogen metabolites. In: Burtis CA, Ashwood ER (eds) Tietz book of clinical chemistry. Saunders, Philadelphia, pp 1239-1242
    • (1999) Tietz Book of Clinical Chemistry , pp. 1239-1242
    • Newmann, D.J.1    Price, C.P.2
  • 24
    • 0021813187 scopus 로고
    • Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
    • 1:CAS:528:DyaL2MXlslKnu7k%3D 3899825 10.1007/BF00280883
    • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
    • (1985) Diabetologia , vol.28 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3    Naylor, B.A.4    Treacher, D.F.5    Turner, R.C.6
  • 26
    • 7444270286 scopus 로고    scopus 로고
    • Role of chromium in human health and in diabetes
    • 1:CAS:528:DC%2BD2cXhtVKis7zK 15505017 10.2337/diacare.27.11.2741
    • Cefalu WT, Hu FB (2004) Role of chromium in human health and in diabetes. Diabetes Care 27:2741-2751
    • (2004) Diabetes Care , vol.27 , pp. 2741-2751
    • Cefalu, W.T.1    Hu, F.B.2
  • 27
    • 0030695031 scopus 로고    scopus 로고
    • Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes
    • 1:CAS:528:DyaK2sXntVKisbo%3D 9356027 10.2337/diab.46.11.1786
    • Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J (1997) Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46:1786-1791
    • (1997) Diabetes , vol.46 , pp. 1786-1791
    • Anderson, R.A.1    Cheng, N.2    Bryden, N.A.3    Polansky, M.M.4    Cheng, N.5    Chi, J.6    Feng, J.7
  • 28
    • 0027949040 scopus 로고
    • Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM
    • 1:STN:280:DyaK2M7ovVKrtg%3D%3D 7882815 10.2337/diacare.17.12.1449
    • Lee NA, Reasner CA (1994) Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 17:1449-1452
    • (1994) Diabetes Care , vol.17 , pp. 1449-1452
    • Lee, N.A.1    Reasner, C.A.2
  • 29
    • 0032946588 scopus 로고    scopus 로고
    • Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium
    • 10.1002/(SICI)1520-670X(1999)12:2<55: AID-JTRA2>3.0.CO;2-G
    • Cheng N, Zhu X, Shi H, Wu W, Chi J, Cheng J, Anderson RA (1999) Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium. J Trace Elem Exp Med 12:55-60
    • (1999) J Trace Elem Exp Med , vol.12 , pp. 55-60
    • Cheng, N.1    Zhu, X.2    Shi, H.3    Wu, W.4    Chi, J.5    Cheng, J.6    Anderson, R.A.7
  • 30
    • 80054759769 scopus 로고    scopus 로고
    • Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients
    • 21170603 10.1007/s12011-010-8917-5
    • Król E, Krejpcio Z, Byks H, Bogdański P, Pupek-Musialik D (2011) Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients. Biol Trace Elem Res 143(2):726-737
    • (2011) Biol Trace Elem Res , vol.143 , Issue.2 , pp. 726-737
    • Król, E.1    Krejpcio, Z.2    Byks, H.3    Bogdański, P.4    Pupek-Musialik, D.5
  • 31
    • 14644419566 scopus 로고    scopus 로고
    • Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: A randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance
    • 15735214 10.2337/diacare.28.3.712
    • Gunton JE, Cheung NW, Hitchman R, Hams G, O'Sullivan C, Foster-Powell K, McElduff A (2005) Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diabetes Care 28:712-713
    • (2005) Diabetes Care , vol.28 , pp. 712-713
    • Gunton, J.E.1    Cheung, N.W.2    Hitchman, R.3    Hams, G.4    O'Sullivan, C.5    Foster-Powell, K.6    McElduff, A.7
  • 32
    • 66749115476 scopus 로고    scopus 로고
    • Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults
    • 1:CAS:528:DC%2BD1MXlt1Cqtro%3D 19422140 10.1089/met.2008.0048
    • Iqbal N, Cardillo S, Volger S, Bloedon LT, Anderson RA, Boston R, Szapary PO (2009) Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults. Metab Syndr Relat Disord 7:143-150
    • (2009) Metab Syndr Relat Disord , vol.7 , pp. 143-150
    • Iqbal, N.1    Cardillo, S.2    Volger, S.3    Bloedon, L.T.4    Anderson, R.A.5    Boston, R.6    Szapary, P.O.7
  • 33
    • 33745002690 scopus 로고    scopus 로고
    • Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: A randomized, double-blind, placebo-controlled trial
    • 1:CAS:528:DC%2BD28XislOksLc%3D 16505499 10.2337/diacare.29.03.06.dc05- 1453
    • Kleefstra N, Houweling S, Jansman FGA, Groenier KH, Gans ROB, Mayboom-de Jong B, Bakker SJ, Bilo HJ (2006) Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 29:521-525
    • (2006) Diabetes Care , vol.29 , pp. 521-525
    • Kleefstra, N.1    Houweling, S.2    Jansman, F.G.A.3    Groenier, K.H.4    Gans, R.O.B.5    Mayboom-De Jong, B.6    Bakker, S.J.7    Bilo, H.J.8
  • 34
    • 0032585689 scopus 로고    scopus 로고
    • + decreases plasma cholesterol and triglycerides in rats: Towards chromium-containing therapeutics
    • 1:CAS:528:DC%2BD3cXhslWmsg%3D%3D
    • + decreases plasma cholesterol and triglycerides in rats: towards chromium-containing therapeutics. J Inorg Biochem 4:838-845
    • (1999) J Inorg Biochem , vol.4 , pp. 838-845
    • Sun, Y.1    Mallya, K.2    Ramirez, J.3    Vincent, J.B.4
  • 35
    • 84856386162 scopus 로고    scopus 로고
    • Lipid profile and insulin sensitivity in rats fed with high-fat or high-fructose diets
    • 1:CAS:528:DC%2BC3MXhsVeqtrvK 22005430 10.1017/S0007114511004454
    • Zaman MQ, Leray V, Le Bloc'h J, Thorin C, Ouguerram K, Nguyen P (2011) Lipid profile and insulin sensitivity in rats fed with high-fat or high-fructose diets. Br J Nutr 106(Suppl 1):S206-210
    • (2011) Br J Nutr , vol.106 , Issue.SUPPL. 1 , pp. 206-210
    • Zaman, M.Q.1    Leray, V.2    Le Bloc'H, J.3    Thorin, C.4    Ouguerram, K.5    Nguyen, P.6
  • 37
    • 34547479904 scopus 로고    scopus 로고
    • Fructose and the metabolic syndrome: Pathophysiology and molecular mechanisms
    • 10.1301/nr.2007.jun.S13-S23
    • Rutledge AC, Adeli K (2007) Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr Rev 65:13-23
    • (2007) Nutr Rev , vol.65 , pp. 13-23
    • Rutledge, A.C.1    Adeli, K.2
  • 38
    • 78349283092 scopus 로고    scopus 로고
    • Fructose: A highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome
    • 1:CAS:528:DC%2BC3cXhsFSgu7nF 20823452 10.1152/ajpendo.00283.2010
    • Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K (2010) Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 299(5):E685-694
    • (2010) Am J Physiol Endocrinol Metab , vol.299 , Issue.5 , pp. 685-694
    • Dekker, M.J.1    Su, Q.2    Baker, C.3    Rutledge, A.C.4    Adeli, K.5
  • 39
    • 40049101869 scopus 로고    scopus 로고
    • Dietary fructose and the metabolic syndrome
    • 1:CAS:528:DC%2BD1cXisVelur4%3D 18301272 10.1097/MOG.0b013e3282f3f4c4
    • Miller A, Adeli K (2008) Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol 24(2):204-209
    • (2008) Curr Opin Gastroenterol , vol.24 , Issue.2 , pp. 204-209
    • Miller, A.1    Adeli, K.2
  • 40
    • 34250718183 scopus 로고    scopus 로고
    • Vascular angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats
    • 1:CAS:528:DC%2BD2sXovFKitrg%3D 17587757 10.1291/hypres.30.451
    • Nyby MD, Abedi K, Smutko V, Eslami P, Tuck ML (2007) Vascular angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats. Hypertens Res 30(5):451-457
    • (2007) Hypertens Res , vol.30 , Issue.5 , pp. 451-457
    • Nyby, M.D.1    Abedi, K.2    Smutko, V.3    Eslami, P.4    Tuck, M.L.5
  • 41
    • 84879296381 scopus 로고    scopus 로고
    • Glucose homeostasis can be differentially modulated by varying individual components of a western diet
    • 1:CAS:528:DC%2BC3sXnvFGrsA%3D%3D 23313044 10.1016/j.jnutbio.2012.09.009
    • Forbes JM, Cowan SP, Andrikopoulos S, Morley AL, Ward LC, Walker KZ, Cooper ME, Coughlan MT (2013) Glucose homeostasis can be differentially modulated by varying individual components of a western diet. J Nutr Biochem 24(7):1251-1257
    • (2013) J Nutr Biochem , vol.24 , Issue.7 , pp. 1251-1257
    • Forbes, J.M.1    Cowan, S.P.2    Andrikopoulos, S.3    Morley, A.L.4    Ward, L.C.5    Walker, K.Z.6    Cooper, M.E.7    Coughlan, M.T.8
  • 43
    • 80054766994 scopus 로고    scopus 로고
    • The effects of chromium complex and level on glucose metabolism and memory acquisition in rats fed high-fat diet
    • 1:CAS:528:DC%2BC3MXht1OisbrJ 21120707 10.1007/s12011-010-8905-9
    • Sahin K, Tuzcu M, Orhan C, Agca CA, Sahin N, Guvenc M, Krejpcio Z, Staniek H, Hayirli A (2011) The effects of chromium complex and level on glucose metabolism and memory acquisition in rats fed high-fat diet. Biol Trace Elem Res 143(2):1018-1030
    • (2011) Biol Trace Elem Res , vol.143 , Issue.2 , pp. 1018-1030
    • Sahin, K.1    Tuzcu, M.2    Orhan, C.3    Agca, C.A.4    Sahin, N.5    Guvenc, M.6    Krejpcio, Z.7    Staniek, H.8    Hayirli, A.9
  • 45
    • 78349269587 scopus 로고    scopus 로고
    • Chromium (D-phenylalanine)3 alleviates high fat-induced insulin resistance and lipid abnormalities
    • 1:CAS:528:DC%2BC3cXhsFahsrrE 3046066 21134603 10.1016/j.jinorgbio.2010. 09.008
    • Kandadi MR, Unnikrishnan MK, Warrier AK, Du M, Ren J, Sreejayan N (2011) Chromium (D-phenylalanine)3 alleviates high fat-induced insulin resistance and lipid abnormalities. J Inorg Biochem 105(1):58-62
    • (2011) J Inorg Biochem , vol.105 , Issue.1 , pp. 58-62
    • Kandadi, M.R.1    Unnikrishnan, M.K.2    Warrier, A.K.3    Du, M.4    Ren, J.5    Sreejayan, N.6
  • 46
    • 77954214574 scopus 로고    scopus 로고
    • Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HIJ mice
    • 1:CAS:528:DC%2BC3cXosV2lsrs%3D 20513351 10.1016/j.bbrc.2010.05.129
    • Chen WY, Chen CJ, Liu CH, Mao FC (2010) Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HIJ mice. Biochem Biophys Res Commun 397(3):459-464
    • (2010) Biochem Biophys Res Commun , vol.397 , Issue.3 , pp. 459-464
    • Chen, W.Y.1    Chen, C.J.2    Liu, C.H.3    Mao, F.C.4
  • 47
    • 34547811377 scopus 로고    scopus 로고
    • Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: The fat-fed, streptozotocin-treated rat
    • 1:CAS:528:DC%2BD2sXovFehsbc%3D 17697867 10.1016/j.metabol.2007.04.021
    • Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, Sriramoju V, Juturu V, Komorowski JR (2007) Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metab Clin Exp 56:1233-1240
    • (2007) Metab Clin Exp , vol.56 , pp. 1233-1240
    • Sahin, K.1    Onderci, M.2    Tuzcu, M.3    Ustundag, B.4    Cikim, G.5    Ozercan, I.H.6    Sriramoju, V.7    Juturu, V.8    Komorowski, J.R.9
  • 49
    • 84875979239 scopus 로고    scopus 로고
    • Dietary chromium(III) propionate complex supplementation affects tissue mineral levels in rats fed high-fructose diet
    • Król E, Krejpcio Z (2013) Dietary chromium(III) propionate complex supplementation affects tissue mineral levels in rats fed high-fructose diet. J Elem 18(1):91-98
    • (2013) J Elem , vol.18 , Issue.1 , pp. 91-98
    • Król, E.1    Krejpcio, Z.2
  • 50
    • 73949157960 scopus 로고    scopus 로고
    • The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats
    • 1:CAS:528:DC%2BD1MXhtFOrsb7I 19271160 10.1007/s12011-009-8351-8
    • Dogukan A, Sahin N, Tuzcu M, Juturu V, Orhan C, Onderci M, Komorowski J, Sahin K (2009) The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats. Biol Trace Elem Res 131:124-132
    • (2009) Biol Trace Elem Res , vol.131 , pp. 124-132
    • Dogukan, A.1    Sahin, N.2    Tuzcu, M.3    Juturu, V.4    Orhan, C.5    Onderci, M.6    Komorowski, J.7    Sahin, K.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.